FDA should step in to help spur AI/ML standards

RAPS

13 June 2022 - The US FDA should support the burgeoning integration of artificial intelligence and machine learning in medical devices by encouraging the development of new standards and setting deadlines for their implementation.

That’s according to Brad Thompson, a regulatory attorney at Epstein, Becker and Green. Thompson spoke with Regulatory Focus on the state of artificial intelligence and machine learning and what can be done to help move the regulatory needle forward. 

While he supports organisations coming up with standards on their own, he says regulators should speed things up.

Read Regulatory Affairs Professional Society article

Michael Wonder

Posted by:

Michael Wonder